CRT - 2018

Adam Greenbaum, MD, joined Emory after serving at Henry Ford Heart and Vascular Institute in Detroit, Michigan for the past 19 years as Co-director of the Center for Structural Heart Disease, Director of the Cardiac Catheterization Laboratory and Director of the Interventional Fellowship Program. He has dedicated his career to patient care, clinical research and fellow and resident education. Dr. Greenbaum has received numerous patient care and teaching awards, and is recognized as a clinical expert in the field of structural heart disease. His breakthrough research surrounding structural heart problems and the minimally invasive techniques he developed as a result, gives patients new treatment options. And his novel transcatheter methods and approaches to valvular heart disease bring new hope to patients with no other options. He is board certified in general and interventional cardiology and is a Fellow of the American College of Cardiology, the American Heart Association and the Society for Cardiovascular Angiography and Interventions. Dr. Greenbaum graduated from the New York University School of Medicine in New York, NY. He completed his internal medicine training at the University of Michigan in Ann Arbor, MI and his general and interventional cardiology training at Duke University in Durham, NC.

Adhir Shroff is a cardiologist at UIC Medical Centre, Chicago, Illinois, USA.

Ahmed Mashaly is a cardiologist at Tanta University, Egypt.

Ajar Kochar is an interventional cardiologist at Duke University Medical Center.

Ajay J. Kirtane, MD, SM, is a Professor of Medicine at Columbia University Medical Center and Director of the Cardiac Catheterization Laboratories at New York Presbyterian Hospital. Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency in Internal Medicine at the University of California – San Francisco. Dr. Kirtane is a practicing Cardiologist with an interest in coronary and peripheral intervention and assumed the directorship of the NYP/Columbia cardiac catheterization laboratories in 2015. In addition to his clinical commitments at CUMC, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Center for Interventional Vascular Therapy. On the national and international level, he is a co-director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics meeting, has served as a director of several international, national, and regional educational meetings, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He has authored/co-authored >150 original manuscripts and >50 reviews and chapters including the “Coronary Stenting” chapters of the two most widely used textbooks in Interventional Cardiology.

Akram W Ibrahim is an interventional cardiology at Emory University Hospital, Atlanta, GA, USA.

Akshay Bagai is an assistant professor of medicine at University of Toronto, Toronto, Canada.

Works at San Raffaele Hospital, Milan, Lombardia, Italy. Features in 6 videos on Wondr Medical. Alaide Chieffo generally speaks on Bifurcation, Left Main Stem (LMS), Intravascular Ultrasound (IVUS), Coronary Optical Coherence Tomography (OCT), and Covid-19.

Alexander Truesdell works at Virginia Heart, Falls Church, VA, USA.

Dr. Lansky is a Professor of Medicine in the section of Cardiology at the Yale School of Medicine, and is a practicing cardiologist at Yale-New Haven Hospital in New Haven, CT. She has dedicated her career to leading clinical and angiographic evaluations of more than 500 clinical trials in a broad range of ischemic cardiovascular therapeutic areas, including pharmacologic and interventional device trials, many of which are landmark trials in the field and/or leading to FDA approval in the United States. She has served as the principal investigator on numerous national and international imaging studies, devices, DES, and neuroprotection trials. Dr. Lansky has authored and coauthored over 500 academic peer-reviewed manuscripts in the fields of interventional cardiology, angiography, and women’s cardiovascular health. She chaired the American Heart Association Statement on Interventions in Women and most recently the Academic Research Consortium defining Neurologic Endpoints in clinical cardiovascular trials.

Alexandre Abizaid is a consultant cardiologist at Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.

Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.

Works at CVPath Institute, Inc., Gaithersburg, MD, USA. Features in 2 videos on Wondr Medical. Aloke Finn generally speaks on Drug coated balloons (DCB), Primary Percutaneous Coronary Intervention (PPCI), Stents, Drug Eluting Stents (DES), and In-stent Restenosis (ISR).

Dr. Anthony A Bavry is a Professor of Medicine at UT Southwestern Medical Center and Director of Structural Heart Interventions. He is an Interventional Cardiologist with over 10 years of experience in the field. He specializes in transcatheter aortic and mitral valve procedures. His research interests include hemodynamic assessment during TAVR, ischemic heart disease, acute coronary syndrome/thrombectomy, anti-platelet/anti-coagulant therapy, and fractional flow reserve/intravascular ultrasound. He has performed numerous meta-analyses on these topics and has conducted various clinical trials.

Arie Pieter Kappetein works at Thorax Centre Erasmus MS, Rotterdam, The Netherlands.

A consultant cadiologist at Clinique Pasteur, European excellence center for Hypertension, Toulouse, France. Features in 35 videos on Wondr Medical. Atul Pathak generally speaks on Hypertension and Renal Denervation (RDN).

Axel Linke works at University of Leipzig, Heart Center, Leipzig, Sachsen, Germany.

Works at Montefiore Medical Center, New York, NY, US. Features in 40 videos on Wondr Medical. Azeem Latib generally speaks on Bioresorbable Vascular Scaffold (BVS), Drug Eluting Stents (DES), Intravascular Ultrasound (IVUS), Bifurcation, and Intracoronary Imaging.

Works at ASST Fatebenefratelli-Sacco Milan, Milan, Italy. Features in 1 video on Wondr Medical. Bernardo Cortese generally speaks on Medical Device.

An interventional cardiology at Intermountain Heart Institute, Murray, UT, USA. Features in 4 videos on Wondr Medical. Brian Whisenant generally speaks on Mitral regurgitation, Mitral, Trans Mitral Valve Implantation (TMVR), and MitraClip.

Dr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center (CSMC) in Los Angeles, California. Dr. Samuels completed his medical studies at Albert Einstein College of Medicine in New York before returning to Southern California to complete his residency and chief residency in Internal Medicine at Harbor-UCLA Medical Center. At CSMC, he trained in both general and interventional cardiology before joining the medical staff there. In addition to his clinical practice in coronary intervention, Dr. Samuels has actively participated in numerous interventional trials including IVUS guided therapy, coronary physiology and microvascular disease. He is also working closely with the Barbra Streisand Women’s Heart Center based at CSMC, working as an interventionalist in the active coronary reactivity research there. As co-chair of a 30-day readmissions task force, he has helped to shape policy for CSMC in its efforts to improve quality delivery of care. He has frequently been invited as faculty to many scientific meetings and is a sought after speaker for numerous peer educational platforms. Dr. Samuels is a fellow of the American College of Cardiology and is Board Certified in Internal Medicine, Cardiovascular Diseases, and Interventional Cardiology. He is married with three sons; his outside interests include contemporary art and long distance running.

Works at University of Saarland, Homburg, Saarland, Germany. Features in 4 videos on Wondr Medical. Bruno Scheller generally speaks on Drug Coated Balloon (DCB), Stroke, Venous (PVD), Peripheral Vascular Disease (PVD), and Aortic Pathology.

Carlo Di Mario is Professor of Cardiology at the University of Florence and Director of the Structural 
Interventional Cardiology Division of the University Hospital Careggi, Florence, Italy. Previous posts included 15 years as Professor of Clinical Cardiology at Imperial College of Sciences, Medicine & Technology, London and Consultant Cardiologist at the Royal Brompton Hospital. Despite his teaching, research and administrative commitments, he maintains an active clinical involvement performing more than 100 PCI per year with special interest in the treatment of calcified lesions, chronic total occlusions, bifurcations, and diffuse disease. He is a regular TAVI operator and certified implanter for the Medtronic Evolut R and Edwards Sapien 3 transcatheter aortic valves. He participated in more than 160 MitraClip implantations in London and Florence and has recently started direct annuloplasty with the CardioBand. Professor Di Mario pioneered the use of intracoronary Doppler, pressure measurement, intravascular ultrasound, optical coherence tomography, and near infrared spectroscopy. He was PI of the OPTICUS trial, failing to demonstrate superiority of IVUS guided stenting, and of the Lipid Rich Plaque study, due to report at TCT 2018. He was Principal Investigator of the DESTINI trial, using Doppler CRF to identify lesions in need of stenting, and of the CARESS in AMI trial, a large multicentre trial showing that patients who receive fibrinolytic therapy for ST-elevation myocardial infarction benefit from early angioplasty. This trial and a subsequent meta-analysis have led to a change in the European Society of Cardiology and AHA/ACC Guidelines for treatment of STEMI patients. He cooperated with Dr Davies to the validation of iFR to assess lesion severity and discriminate the contribution of individual lesions, and with Dr Lyon in the intracoronary delivery of SERCA-2 genes via adenoviral vectors in the CUPID2 trial.

A consultant cardiologist at Hackensack University Medical Center, New Jersey, USA. Features in 2 videos on Wondr Medical. Carlos Ruiz generally speaks on Mitral.

Chad League is a manager at MedStar Health Research Institute, Inc., Hyattsville, MD, USA.

Christian Spaulding is an interventional cardiology at Hôpital européen Georges Pompidou, Paris, France.

Dr Christopher Cook is a Medical Research Council Clinical Fellow at Imperial College London, undertaking a PhD in coronary physiology under the supervision of Dr Justin Davies. He studied Medicine at University College London (UCL) and graduated with Distinction (Clinical Medicine and Clinical Sciences) in his final MBBS Examinations in 2009. He achieved a First Class (Honours) Bachelor of Science degree in Physiology undertaking a period of research at The Hatter Cardiovascular Institute. He was awarded ‘The Dean’s List’ for outstanding performance in the Faculty of Life Sciences. In total he was awarded 17 prizes including the prestigious Gold Medal Medicine (proxime accessit). In 2014, he was awarded the Imperial Valve and Cardiovascular Course Young Investigator Prize. In 2015 he was awarded the inaugural EuroPCR’s Got Talent Award. In 2017 he was elected onto the EuroPCR Clinical Programme Committee.

Works at Ochsner Medical Institutions, New Orleans, LA, USA. Features in 1 video on Wondr Medical. Christopher White generally speaks on Stroke, Peripheral Vascular Disease (PVD), and Live Cases.

Chuck Simonton is an industry at Abbott Vascular.

Dr. Clemens von Birgelen is a Professor of Cardiology at the University of Twente, Enschede, and Co-Director of the Department of Cardiology at Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede.

Works at Kingwood Medical Center-HCA, Houston, TX, USA. Features in 1 video on Wondr Medical. Clifford DeBruce generally speaks on General.

A consultant cardiologist at Mater Private Hospital, Dublin, Ireland. Features in 20 videos on Wondr Medical. Colm Hanratty generally speaks on Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Chronic Total Occlusion (CTO), Calcium Scoring, and Stable Coronary Artery Disease (CAD).

Constantino S. Pena is an interventional radiology at Miami Cardiac & Vascular Institute, Miami, FL, USA.

Crispin Davies is a cardiologist at Oregon Health and Science University, Portland, Oregon, USA.

Dabit Arzamendi Aizpurua is an interventional cardiologist at Centro Médico Teknon, Barcelona, Spain.

Dan Feldman is a cardiology fellow at UIC Medical Centre, Chicago, Illinois, USA.

Daniel Chamié, MD, PhD concluded his interventional cardiology training at Dante Pazzanese Institute of Cardiology in Sao Paulo, Brazil, in 2009. Between 2010 and 2012 he served as research associate at the intravascular imaging core lab at University Hospitals, Case Medical Center, Cleveland, OH, where he advanced his knowledge in the use of intracoronary physiology and imaging, particularly OCT. Upon his return to Brazil, practiced as an interventional cardiologist at Dante Pazzanese Institute, developing experience in complex PCI and intracoronary imaging and physiology. Over the last decade, he also has been involved in clinical research on the assessment of novel drug-eluting stents and bioresorbable scaffolds and was the leading investigator of the iSIGHT trial, proposing an algorithmic approach in the use of intravascular imaging to guide PCI. In parallel with his clinical activities, he served as director of the OCT core lab at the Cardiovascular Research Center from 2012 to 2020. During this time, he developed OCT analysis methods for several studies on novel devices (e.g. bioresorbable scaffolds, drug-eluting stents, specialty balloons) in various clinical scenarios (e.g. stable CAD, ACS, bifurcation lesions, high-bleeding risk patients, etc). Since 2022, he has practiced as the Director of Invasive Cardiovascular Imaging at the Yale School of Medicine, New Haven, CT, and is the director of the Intravascular Imaging and Physiology Core Laboratories at the Yale Cardiovascular Research Group.

David J. Cohen, MD, MSc is currently Director of Clinical and Outcomes Research at the Cardiovascular Research Foundation (New York, NY) and Director of Academic Affairs at St. Francis Hospital (Roslyn, NY). Previously, he was Professor of Medicine at the University of Missouri–Kansas City and Director of Cardiovascular Research and Medical Director of Health Economics and Technology Assessment at Saint Luke’s Mid America Heart Institute. Heart Institute where he continues to direct the Health Economics and Technology Assessment Group. Dr. Cohen earned his M.D. at Harvard Medical School and his Master's degree in Health Policy at the Harvard School of Public Health. He did his clinical training at Brigham and Women's Hospital and was a clinical and research fellow in cardiology at Beth Israel Hospital for five years. Dr. Cohen is a practicing interventional cardiologist with a focus on structural and valvular heart disease. His research focuses on the application of formal cost-effectiveness methodology to novel interventions for cardiovascular disease (CVD), the extension of traditional cardiovascular outcomes research to include patient-centered outcomes, and the development and evaluation of instruments for assessing CVD patients’ health status and preferences. He is also active in research to determine the short- and long-term outcomes of new devices for percutaneous coronary revascularization and identifying the optimal target populations and techniques for these devices. Dr. Cohen has published more than 500 original articles in leading journals, including the New England Journal of Medicine, Lancet, JAMA, Circulation, and the Journal of the American College. Dr. Cohen serves on the editorial board for the American Heart Journal, JACC Interventions, and Circulation and reviews for the American Journal of Cardiology, Journal of the American College of Cardiology, New England Journal of Medicine, JAMA, and Medical Decision Making.

Dr. David E. Kandzari is the Chief of the Piedmont Heart Institute and Cardiovascular Service Line; Director, Interventional Cardiology of the Piedmont Heart Institute; and Chief Scientific Officer for Piedmont Healthcare in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari is the former Director of Interventional Cardiology Research at the Scripps Clinic in La Jolla, California. Before joining the Scripps faculty, he also served as Chief Medical Officer for the Cordis Corporation, a Johnson & Johnson Company. He has also served as a Medical Officer for the Center for Devices and Radiological Health for the United States Food and Drug Administration. Board certified by the American Board of Internal Medicine and its subspecialty Board of Cardiovascular Disease and Board of Interventional Cardiology, Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 400 studies, book chapters and scientific reviews, and has delivered more than 700 lectures, both nationally and internationally, on a variety of issues related to both interventional and general cardiology. Dr. Kandzari has been consecutively voted as one of Atlanta's Top Doctors by Atlanta Magazine from 2011 to 2021, and is peer-nominated in the top 1% of cardiologists by U.S News and World Report.

Works at The Christ Hospital Heart and Vascular Center/The Lindner Research Center, Cincinnati, OH, USA. Features in 9 videos on Wondr Medical. Dean Kereiakes generally speaks on Peripheral Vascular Disease (PVD), Coronary Interventions, Impella, Shockwave Lithotripsy (Coronary), and Transcatheter Aortic Valve Implantation (TAVR / TAVI).

An interventional cardiology at Clinique Pasteur, Toulouse, France. Features in 3 videos on Wondr Medical. Didier Tchétché generally speaks on Medical Device.

Dr. William Fearon graduated from Dartmouth College and received his medical degree from Columbia University College of Physicians and Surgeons, where he was elected into the Alpha Omega Alpha Medical Honor Society. He completed an Internal Medicine residency at Stanford University Medical Center serving an extra year as a Medical Chief Resident. He completed a General Cardiology and Interventional Cardiology fellowship at Stanford, spending his third year as the Chief Cardiology Fellow. He is currently a Professor of Cardiology and Director of Interventional Cardiology at Stanford University School of Mediciner. Dr. Fearon is board certified in cardiovascular medicine and interventional cardiology, and he is a fellow of the American College of Cardiology, the American Heart Association, and the Society of Cardiovascular Angiography and Interventions. He has been elected to the American Society for Clinical Investigation. Dr. Fearon’s primary area of research interest is in coronary physiology. He was the US principal investigator and senior author of the FAME trial, published in the New England Journal of Medicine and was a co-principal investigator and senior author of the FAME 2 trial, also published in the New England Journal of Medicine. He is now the principal investigator of the international FAME 3 trial comparing bypass surgery to fractional flow reserve guided percutaneous coronary intervention. He serves on the editorial board of the Journal of the American College of Cardiology, Circulation, JACC Cardiovascular Interventions, and Circulation: Cardiovascular Interventions. He was the principal investigator on an R01 and is the PI on an R61/R33 NIH award evaluating cardiac allograft vasculopathy early after transplantation. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement. He was a coauthor on the PARTNER 2A Trial published in the New England Journal of Medicine.

Edo Kaluski works at New Jersey Medial School, New York, USA.

Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI is Director of the Center for Complex Coronary Interventions at the Minneapolis Heart Institute and Chairman of the Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation. After graduating from Lycee Leonin de Patissia, Dr. Brilakis received his medical degree from the National Kapodistrian University of Athens, Greece. He trained in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology at the Mayo Clinic. He also completed a Masters in Clinical Research at the Mayo Clinic and a PhD in Clinical Research at the National Kapodistrian University of Athens, Greece. He served as director of the cardiac catheterization laboratories at VA North Texas Health Care System from 2004-2016. He was on the faculty of the University of Texas Southwestern Medical School from 2004-2018. Dr. Brilakis leads a large clinical trial group investigating treatment of chronic total occlusions, prevention and treatment of saphenous vein graft disease, prevention and management of complications, intracoronary imaging, antiplatelet treatment optimization post coronary stenting, radiation safety in the catheterization laboratory, and implementation of novel technologies in healthcare. Dr. Brilakis has authored or co-authored over 600 manuscripts and has written the Manual of CTO Interventions, now in its second edition. He directs the Complex Coronary Interventions Webcast series and is on the Board of the Cardiovascular Innovations Foundation. He is an associate editor for Circulation and an editorial board member and reviewer for several journals and grant agencies. He is lecturing and proctoring at several institutions in the United States and abroad.

Eric Bates works at University of Michigan Medical Center, Ann Arbor, MI, USA.

Works at Vascular Institute of the Midwest, PC, USA. Features in 4 videos on Wondr Medical. Eric Dippel generally speaks on Peripheral Vascular Disease (PVD), Atherectomy, Live Cases, Endovascular, and Chronic Total Occlusion (CTO).

Works at MCRN, Washington, District of Columbia, USA. Features in 2 videos on Wondr Medical. Federico Asch generally speaks on Intervention and Coronary Interventions.

Professor Felix Mahfoud is an Associate Professor and senior physician of Internal Medicine and Cardiology at Saarland University Hospital, and Affiliate/Visiting Professor Harvard-MIT Biomedical Engineering, Institute of Medical Engineering and Science, Cambridge, US. Professor Mahfoud completed training in Cardiology and Interventional Cardiology at the Department for Internal Medicine III, Saarland University Hospital, Germany in 2014. Since 2017, he has served as Vice Chairman of the ‘Working Group on Interventional Hypertension Treatment’ for the European Society of Hypertension, and as a Committee Member of the 2018 Hypertension Guidelines.

Finn Donaldson is an assistant director at FDA, Maryland, US.

An interventional cardiology at Universitäres Herzzentrum Zürich, Zürich, Switzerland. Features in 4 videos on Wondr Medical. Francesco Maisano generally speaks on Mitral regurgitation, Mitral, Trans Mitral Valve Implantation (TMVR), and MitraClip.

Fritz Angle works at University of Virginia, Charlottesville, VA, USA.

Gary S. Mintz, MD, is a Senior Medical Advisor at the Cardiovascular Research Foundation (CRF, New York, NY) and a Director of Transcatheter Cardiovascular Therapeutics (TCT). He is the author of more than 1000 peer reviewed articles, 60 book chapters, 4 books, and 850 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and (especially) intravascular imaging and physiology. In 2005, Dr. Mintz published his single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese. In 2014, Dr. Mintz received the Master of the Masters Career Achievement Award at the TCTAP-Cardiovascular Summit in Seoul, Korea; in 2015 Dr. Mintz received the Chien Foundation Outstanding Lectureship & Lifetime Achievement Award, also presented at TCTAP-Cardiovascular Summit in Seoul, Korea; in 2017 Dr. Mintz received the Outstanding Achievement Award at CBS 2017, Nanjing, China; in 2018 Dr. Mintz received the Career Achievement Award at NFIC in Krakow, Poland; and in 2020 Dr. Mintz received the Jiangsu Friendship Award from the People’s Government of Jiangsu Province, China, the highest award presented to a non-Chinese. He also serves as a Senior Scientist and Advisor at the Medstar Cardiovascular Research Network, Washington, DC. Dr. Mintz completed his undergraduate education at the University of Pennsylvania in 1970 and received his medical degree from Hahnemann University (now part of Drexel University), in 1974, both in Philadelphia, PA. He finished his internship in 1975, residency in 1976, and cardiology fellowship in 1978, each at Hahnemann University. He joined the Hahnemann University Department of Medicine faculty in 1978 and was ultimately promoted to Professor of Medicine in 1987 before joining CRF in 1991. His past appointments at CRF have included Chief Medical Officer and Editor-in-Chief (and one of the founders) of TCTMD.com.

Works at Rush University Medical Center, Chicago, IL, USA. Features in 1 video on Wondr Medical. Gary Schaer generally speaks on Acute Coronary Syndromes (ACS), Anti-Platelet Drugs , and Anticoagulants.

George S. Hanzel, MD has joined Emory Healthcare and Emory University School of Medicine as an Associate Professor of Medicine. He is certified by the American Board of Internal Medicine in Cardiovascular Diseases and Interventional Cardiology. A graduate of Georgetown University School of Medicine in Washington, D.C., Dr. Hanzel completed his internship at the National Naval Medical Center in Bethesda, Maryland, his residency at Walter Reed Army Medical Center and then his cardiology fellowship at the National Naval Medical Center. Dr. Hanzel then served in the United States Navy, Lieutenant Commander, as a staff cardiologist at the Great Lakes Naval Hospital from 1999 to 2002. He completed an interventional cardiology fellowship in June 2004 at Beaumont Hospital in Royal Oak, Michigan. Dr. Hanzel then joined the Beaumont Hospital Royal Oak cardiology faculty in 2004 serving as Director of the Cardiac Catheterization Laboratory, Director of Structural Heart Disease, and associate professor at Oakland University William Beaumont School of Medicine until 2020. Dr. Hanzel's clinical and research interests include transcatheter aortic valve replacement, transcatheter therapies for mitral and tricuspid valve disease, alcohol septal ablation, and septal closure. Dr. Hanzel is a member of the STS/ACC Transcatheter Valve Therapy Registry Steering Committee and the Society for Cardiovascular Angiography and Interventions Structural Heart Disease Council.

Gholam Ali is an assistant professor of medicine at Tulane university, New Orleans, Louisiana, US.

Dr Giora Weisz is the Section-Head and director of the interventional cardiology program at Montefiore Medical Center in New York. He also serves as faculty of the Cardiovascular Research Foundation in New York. Dr Weisz graduated from the Hebrew University-Hadassah Medical School in Jerusalem, Israel. He completed his cardiology fellowship training at the Carmel Medical Center-Technion School of Medicine in Haifa, Israel, and underwent advanced training in interventional cardiology at Lenox Hill Hospital and the Cardiovascular Research Foundation in New York City. Dr Weisz is an internationally recognized researcher focused on innovative technologies in cardiovascular medicine. He has pioneered the use of novel robotic-enhanced coronary interventions, navigation and positioning technologies. Dr Weisz has been the Principal Investigator for pivotal clinical studies leading to FDA approval of cutting-edge technologies for interventional cardiology device positioning and navigation and robotics, as well leading multicenter studies in interventional imaging and the combination of PCI with pharmacological anti-ischemic treatment. Dr Weisz has published extensively in the most prestigious peer-review medical journals. He is an associate-director of TCT, which is the premier interventional cardiology conference, and is a regular faculty member for the most important international cardiovascular meetings.

Gregg W. Stone, MD, FACC, MSCAI is an interventional cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School of Medicine at Mount Sinai in New York, NY. Dr. Stone has served as the national or international principal investigator for more than 120 national and international multicenter randomized trials (many of which have led to new device approval or indications in the US), has authored more than 2000 manuscripts and abstracts published in the peer-reviewed literature, and has delivered thousands of invited lectures around the world. With a 2018 H-factor of 152, Dr. Stone was recently listed in Nature Medicine as one of the most prolific authors in science. Dr. Stone's areas of expertise include interventional therapies of acute coronary syndromes, myocardial infarction and cardiogenic shock; drug-eluting stents and bioresorbable scaffolds; left main and complex coronary artery disease intervention; antiplatelet and antithrombotic pharmacotherapies; transcatheter valve repair and replacement; interventional hypertension and heart failure therapies; left atrial appendage closure; intravascular imaging (IVUS, OCT and NIRS); vulnerable plaque diagnosis and treatment; adjunctive interventional devices including atherectomy, distal embolic protection, thrombectomy, covered stents, chronic total occlusion devices, and brachytherapy; saphenous vein graft therapies; contrast nephropathy; clinical trial design; and regulatory issues. Dr. Stone is the director of TCT, the world's largest symposium devoted to interventional cardiology and vascular medicine. Dr. Stone founded the annual National Interventional Cardiology Fellow's Course and Transcatheter Valve Therapies TVT), the Chronic Total Occlusion (CTO) Summit, and co-directs multiple other meetings in the US, China, Russia, Europe, S. Korea and elsewhere.

Gregory Trachiotis is a cardiothoracic surgeon at Johns Hopkins Medicine, Division of Cardiac Surgery.

Works at Hadassah Medical Center, Jerusalem, Israel. Features in 1 video on Wondr Medical. Haim Danenberg generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI) and Aortic Stenosis (AS).

Hans Bonnier works at University Hospital Brussels, Nuenen, Noord-Brabant, Netherlands.

Hector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart & Vascular Institute and director of the Coronary Invasive Imaging Core Lab. Prior to joining the MHVI medical staff, Dr. Garcia-Garcia served as Director of the Core Lab of Invasive Imaging at Cardialysis—a leading cardiology clinical research organization—and as researcher at the Erasmus Medical Center in Rotterdam, The Netherlands and Inselspital in Bern, Switzerland. He received both a Master’s and Doctorate degree from the Erasmus University of Rotterdam. An accomplished researcher, Dr. Garcia-Garcia has widely published in many international medical journals (more than 530 publications - H-index of 61), authored book chapters in most renowned cardiovascular textbooks and has presented at cardiology conferences world-wide. He is an expert in innovative cardiovascular technology. He has mentored seven PhD students and published their thesis.

Hiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director, Director, Advanced Coronary and MCS at University Hospital Cleveland Medical Center. He is also an Associate Professor, Medicine at Case Western Reserve University School of Medicine. Previously, he served at Massachusetts General Hospital with extensive expertise in Cardiac Imaging, Interventional Cardiology, Optical Coherence Tomography and Computed Tomography.

A fda at Food and Drug Administration, Silver Spring, MD, USA. Features in 2 videos on Wondr Medical. Hiren Mistry generally speaks on Vascular Access (Endovascular).

Works at Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Features in 20 videos on Wondr Medical. Howard Herrmann generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI), Mitral, Mitral regurgitation, MitraClip, and Structural Cardiac Interventions.

Professor Ian Meredith is the Executive Vice President and Global Chief Medical Officer at Boston Scientific. Previously professor and director of Monash Heart, and executive director of the Monash Cardiovascular Research Centre at Monash University in Melbourne, Australia, Professor Meredith has over 25 years of experience as a clinical and interventional cardiologist. Professor Meredith has been a member of the Board of the National Heart Foundation (Australia) and a member of the Cardiac Society of Australia and New Zealand National Board. In 2019, Professor Meredith received a Doctor Laws honoris causa from Monash University for distinguished and exceptional service to the field of medicine and healthcare.

Works at Virginia Commonwealth University/McGuire VAMC, Richmond, VA, USA. Features in 1 video on Wondr Medical. Ion Jovin generally speaks on Chronic Total Occlusion (CTO), Drug Coated Balloon (DCB), and Endovascular.

Dr. Issam D. Moussa is Medical Director of the Carle Heart & Vascular Institute and Clinical Professor of Medicine at Carle Illinois College of Medicine, University of Illinois-UC. Dr. Moussa experience prior to joining Carle Heart & Vascular Institute spanned academic medicine, clinical outcome research, and medical device development. He served as Professor & Clinical Chief of Cardiology at Rutgers Robert Wood Johnson Medical School, in New Brunswick, New Jersey; Professor & Chair of the Division of Cardiovascular Diseases at Mayo Clinic, Florida; Director of Endovascular Service at the Divisions of Cardiology - New York Presbyterian Hospital at Columbia and Cornell Universities; and Director of Interventional Cardiology Research at Lenox Hill Heart & Vascular Institute in New York City. As an interventional cardiologist, Dr. Moussa specializes in performing complex catheter-based cardiovascular procedures in patients with coronary artery disease, structural heart disease, and peripheral arterial disease. Dr. Moussa has been a prolific clinical investigator, he has co-authored over 200 peer-reviewed articles in prominent medical journals and has participated in over 100 clinical trials. His clinical research activities spanned the fields of coronary artery disease, cerebrovascular disease, and structural heart disease. Dr. Moussa has held numerous leadership positions in the American Heart Association, the American College of Cardiology, and the Society of Cardiac Angiography and Intervention. Dr. Moussa has been on the forefront of cardiovascular medical technology development as an innovator, clinical investigator, and an entrepreneur. He currently serves on the Healthcare Innovation Leadership Council of the American College of Cardiology and is the Co-Chair of the Digital Health and Medical Devices work group. Dr. Moussa pursued formal innovation-entrepreneurship education at the Biomedical Innovation Technology Program at Stanford University (2001-2002), and also completed an MBA- healthcare administration at the University of Colorado Business School (2015-2017).

Works at MedStar Washington Hospital Center, Washington, District of Columbia, USA. Features in 4 videos on Wondr Medical. Itsik Ben-Dor generally speaks on Coronary Interventions, Atherectomy, Transcatheter Aortic Valve Implantation (TAVR / TAVI), and General.

Jacques Koolen works at Catharina Hospital, Amsterdam, Noord-Holland, Netherlands.

Jae-Bin Seo works at Boramae Medical Center, Seoul, Korea.

Jaffar is Director of Cardiovascular Innovation and Director of Interventional Electrosurgery at St Francis Hospital and Heart Center, Roslyn, NY. He performs research at the Laboratory of Cardiac Intervention, NHLBI, NIH. He led the invention of transcatheter electrosurgical techniques to cut heart tissue, and together with a team of dedicated physicians and creative thinkers, invented several novel transcatheter procedures and devices that have been translated into clinical practice. He received his undergraduate degree at Cambridge as a Scholar, medical degree at Oxford with merits, and an award-winning PhD in cardiovascular sciences at King’s College London. He completed training in Oxford, London, and Washington DC. He has written over 130 peer-reviewed manuscripts and has given over 50 invited lectures, including 4 late breaking clinical trial presentations. He is a regular live case operator.

James A. Goldstein, MD, FACC, is the the Kojaian Endowed Professor of Research and Education in Cardiology and Director of Cardiovascular Research and Education at Beaumont Hospital, and Professor of Medicine at the Oakland University-William Beaumont School of Medicine in Royal Oak, Michigan. He graduated from the University of Chicago, School of Medicine, in Chicago, IL in 1976 and completed his Clinical and Research Cardiology Fellowships at the Cardiovascular Research Institute at the University of California, San Francisco, CA in 1982. After Fellowship he joined the Cardiology Division at Stanford University, then subsequently joined Washington University-Barnes Hospital where he worked in Interventional Cardiology and directed the Heart Failure-Transplant service. For the past 21 years, Dr. Goldstein has been Director of Research and Education in the Cardiology Division of William Beaumont Hospital. His clinical interests include acute ischemic heart disease, Hemodynamics, congestive heart failure, diseases of the pericardium and bedside physical examination. His Clinical Research interests include hemodynamics, heart failure, RV Infarction, and plaque characterization employing advanced non-invasive and direct coronary imaging techniques. Dr. Goldstein has published over 170 peer-reviewed scientific papers and 20 book chapters. He is a Fellow of the American College of Cardiology and Society of Cardiac Angiography and serves on the Editorial Boards of the Journal of the American College of Cardiology, Catheterization and Cardiovascular Interventions, and Coronary Artery Disease.

James Hermiller works at St. Vincent Medical Group, Indianapolis, IN, USA.

Jason Wasfy works at Massachusetts General Hospital, Boston, MA, USA.

Prof Javier Escaned is Head of Section (Interventional Cardiology Section) at Hospital Clinico San Carlos / Complutense University (Madrid, Spain). He trained in the United Kingdom as Specialist in Cardiology and obtained his PhD in The Netherlands. Author of >600 indexed scientific articles on interventional cardiology, imaging and physiology (h-index 74) and over 30 years of experience as PCI operator, he regularly lectures and performs live cases at major scientific and educational meetings. He is a recipient of the European Society of Cardiology (ESC) Silver Medal and the Andreas Grüntzig Award for his contributions to the fiedl fo Interventional Cardiology. Main areas of expertise include complex PCI, intracoronary diagnostics and functional coronary angiography. His track record in coronary physiology comprises being investigator on pioneer FFR trials like DEFER (1998), collaborator with Justin Davies in the validation and clinical implementation of iFR, and developer of new tools for the assessment of coronary microcirculation. Editorial roles include Deputy Editor EHJ, Advisory Editor Eurointervention, editor of the textbooks “Coronary Stenosis: Imaging, Structure and Physiology” and “Physiological Assessment of Coronary Stenoses and the Microcirculation". Recent board positions include EAPCI board / Education Committee Chair, ESC WG Coronary Pathophysiology and Microcirculation, EuroCTO Board. Recent trials as Principal Investigator include ADVISE II, DEFINE FLAIR, SYNTAX II, PIONEER IV, Cerebral-Coronary-Connection (C3), DCR4Contrast, INOCA LongCovid and AID ANGIO. Additional interests are philosophy and music.

Jay Giri works at University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Jayant Bagai is an assistant professor of medicine at Vanderbilt University, Nashville, Tennessee, USA.

Jeffrey Chambers is a cardiology at Metropolitian Heart and Vascular Institute, Minneapolis, MN, USA.

Jennifer Ellis is a consultant cardiothoracic surgeon at MedStar Washington Hospital Center, Washington, DC, USA.

Ji Bak Kim is a cardiologist at Sejong General Hospital, Gyeonggi, South Korea.

Ji-Hun Ahn works at Soonchunhyang University Gumi Hospital, Gumi, Korea.

Ji-Hyun Kim is a cardiologist at Dongguk University Ilsan Hospital, Dongguk University Graduate School, Goyang, Korea.

Ji-Yeon Hong works at KEPCO Medical Center, Seoul, Korea.

Jie Wang is a consultant cadiologist at Jiangsu Province Hospital Nanjing, China.

Dr. J. Dawn Abbott is the Associate Chief of Faculty Development and Academic Advancement, and Director of the Interventional Cardiology Fellowship Program at Brown Medical School. Her research interests span coronary, endovascular and structural heart disease. She is the principal investigator at Rhode Island Hospital for several multicenter investigator initiated and industry funded trials. She serves as an associate editor for Circulation: Cardiovascular Interventions and is on the editorial board of several cardiovascular journals.

Joao L. Cavalcante is an interventional cardiology at UPMC, Pittsburgh, PA, USA.

Works at University of Pennsylvania, Philadelphia, PA, USA. Features in 1 video on Wondr Medical. Joe Bavaria generally speaks on Cardiovascular Surgery and Aortic dissection.

John Abraham is an orthopedic surgeon at Rothman Orthopaedic Institute, Philadelphia, US.

Works at University of Virginia, Charlottesville, VA, USA. Features in 1 video on Wondr Medical. John Fritz Angle generally speaks on Arterial and Chronic Total Occlusion (CTO).

McLeod Professor of Heart Valve Innovation, University of British Columbia Dr. Webb is the director of interventional cardiology at St. Paul’s Hospital, McLeod Professor at UBC, Medical Director of the Transcatheter Valve Program for the Province of BC. As director of the Centre for Heart Valve Innovation, he leads the group that developed the most widely used transcatheter aortic valve implantation procedures as well as many other first-in-human devices and procedures. He has performed or supervised over 3,000 aortic, mitral, pulmonary, and tricuspid valve procedures in over 30 countries throughout North America, Europe, and Australasia and has authored over 500 publications.

John McB. Hodgson M.D., MSCAI is a Professor of Medicine at CWRU in Cleveland Ohio. He completed his cardiology training at the University of Michigan, and additional Interventional training at Brown University. Since 1985, he has been in academic practice at the Medical College of Virginia, Case Western Reserve University, and the Geisinger Health System. He currently serves as the Director of Cardiology at Wilson Health System. His field of specialization is interventional cardiology, particularly intravascular ultrasound, a technology he helped develop. He is also active in the field of coronary physiology. Dr. Hodgson is a Past President of SCAI and was elected to Masters status with SCAI (MSCAI). He has authored or co-authored over 200 articles, book chapters and interactive teaching tools. He has several medical device patents and has produced award-winning web-based image interpretation tools.

John Laschinger is a fda at Silver Spring, MD, USA.

John McEvoy is a pathologist at Coastal Pathology Laboratories, Charleston, US.

Joon-Hyuk Kong is a cardiothoracic surgeon at Daegu Veterans Hospital, Daegu, Washington.

Works at Cooper University Health Care, Camden, NJ, USA. Features in 2 videos on Wondr Medical. Joseph Lombardi generally speaks on Abdominal Aortic Aneurysm (AAA) and Aortic Pathology.

Judith Veis works at MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Dr Justin Davies is a honorary 
interventional cardiologist at Hammersmith Hospital, Imperial College NHS Trust, London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to
work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents,
he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).

Kate Cohen is a professor of anaesthesia at Massachusetts General Hospital, Boston, USA.

Kendrick Shunk works at VAMC and University of California, San Francisco, CA, USA.

Phone: 617-726-2256 View Location Details About Ken Rosenfield, MD Kenneth Rosenfield, MD, is the Section Head for Vascular Medicine and Intervention and Chairs the Acute Myocardial Infarction(STEMI)Committee for the cardiac cath lab. He is a national leader in treatment of Carotid, Kidney, and Leg artery disease. Dr. Rosenfield is the Section Head for Vascular Medicine and Intervention, who specializes in complex cardiac and vascular interventions and directs the program for treatment of acute myocardial infarction (STEMI) in the cardiac catheterization laboratories. He has spearheaded the development of less-invasive therapies for patients with coronary and vascular disease, both at MGH and nationally, including treatment of Carotid, Kidney, and Leg artery narrowing using stents and other novel devices.

Khalil Ibrahim is a cardiologist at University of Maryland Medical Center, Baltimore, MD, USA.

Dr. Niazi's research has advanced the field of interventional cardiology by focusing on peripheral vascular disease and coronary artery disease. At Emory, Dr. Niazi initiated the peripheral research program that continues to perform multiple studies, including studies for novel devices for FDA approval to help patients' circulation. Dr. Niazi is one of the few cardiologists that treats venous disease along with arterial disease.

Kirk Garratt is a cardiologist at Christiana Care Health System, Newark, DE, USA.

Krishna Rocha-Singh is a consultant cardiologist at Prairie Heart Institute, Prairie Cardiovascular Consultants, Springfield, IL, USA.

Kul Aggarwal is a professor of medicine at University of Missouri Health Care, Columbia, Missouri, USA.

Works at Georgetown/Medstar Washington Hospital Center, Washington, DC, USA. Features in 1 video on Wondr Medical. Kyle Buchanan generally speaks on Acute Coronary Syndromes (ACS), Anti-Platelet Drugs , and Anticoagulants.

Lars Svensson works at Aorta Center and Heart and Vascular Institute, Cleveland, USA.

Works at Brigham and Women's Hospital, Boston, MA, USA. Features in 1 video on Wondr Medical. Laura Mauri generally speaks on Anti-Platelet Drugs and Drug Eluting Stents (DES).

Lawrence Wechsler is a neurologist at University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

Works at Keck School of Medicine of USC, Los Angeles, CA, USA. Features in 3 videos on Wondr Medical. Leonardo Clavijo generally speaks on Drug Eluting Stents (DES), Drug Coated Balloon (DCB), Chronic Limb Ischaemia (CLI, coronary access), Saphenous Venous Disease (SVD), and Superficial veins.

Lowell Satler works at MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Luis A. Guzman is an interventional cardiology at VCU Health Pauley Heart Center, Richmond, VA, USA.

Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology. His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention. His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging. He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee. Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research. His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award. In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology. In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award. Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.

Marc Cohen is a cardiologist at Newark Beth Israel Medical Center, NJ, USA.

Maria Guerrero is a diagnostic radiologist at Ukrainsky Ovchinsky Medical Group, NY, US.

Works at West Virginia Univesity and CAMC Vascular Center of Excellence, Charleston, WV, USA. Features in 1 video on Wondr Medical. Mark Bates generally speaks on Chronic Limb Ischaemia (CLI, coronary access) and Endovascular.

Mark Spence works at Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom.

Marsha Holton works at Cardiovascular Orientation Programs, Mechanicsville, MD, USA.

Dr. Leesar is the Professor of Medicine and section-head of interventional Cardiiology at UAB. His main research is on intravascular ultrasound, coronary physiology, and antiplatelet therapy in patients with ACS. He has conducted several studies and clinical trials. Dr. Leesar has over 25 years experience in interventional cardiology and performs complex coronary intervention. He has resseach support form both NIH and industry.

Matthew Hillebrenner is a bioengineer at U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Mauricio Cohen works at University of Miami Miller School of Medicine, Miami, FL, USA.

Mayra Guerrero works at Evanston Hospital, Evanston, IL, USA.

Micaela Iantorno is an interventional cardiology fellow at MedStar Heart and Vascular Institute, Washington, DC, USA.

Michael Bacharach works at North Central Heart in Sioux Falls, South Dakota, SD, USA.

Michael Dwyer works at University at Buffalo, Buffalo, NY, USA.

Works at Beth Israel Deaconess Medical Center, Boston, MA, USA. Features in 2 videos on Wondr Medical. Michael Gibson generally speaks on Coronary Interventions, Anti-Platelet Drugs , Stable Coronary Artery Disease (CAD), Acute Coronary Syndromes (ACS), and Primary Percutaneous Coronary Intervention (PPCI).

Works at Massachusetts General Hospital, Boston, MA, USA. Features in 5 videos on Wondr Medical. Michael Jaff generally speaks on Drug Eluting Stents (DES), Drug Coated Balloon (DCB), Chronic Limb Ischaemia (CLI, coronary access), and Peripheral Vascular Disease (PVD).

Michael John is a fda at Food and Drug Administration, Silver Spring, MD, USA.

Works at Deutsches Herzzentrum Muenchen, Munich, Bayern, Germany. Features in 13 videos on Wondr Medical. Michael Joner generally speaks on Stents, Drug Eluting Stents (DES), Peripheral Vascular Disease (PVD), Intravascular Ultrasound (IVUS), and Coronary Optical Coherence Tomography (OCT).

Dr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the Associate Director of Interventional Cardiology Research at the UCLA Medical Center. Dr. Lee has published over 110 (over 70 of which were as first author) peer reviewed articles and chapters. He has also published on topics including antithrombotic therapy in patients with acute coronary syndrome and in percutaneous coronary intervention, protocols to establish heparin dosing regimens, and percutaneous coronary intervention for the treatment of left main disease, saphenous vein grafts, and cardiac allograft vasculopathy who have undergone orthotopic heart transplantation. He is one of the world’s authorities in coronary and peripheral orbital atherectomy.

Works at Cleveland Clinic Foundation, Cleveland, OH, USA. Features in 1 video on Wondr Medical. Michael Lincoff generally speaks on Acute Coronary Syndromes (ACS), Anti-Platelet Drugs , and Anticoagulants.

Dr. Michael J. Mack is an internationally renowned cardiothoracic surgeon who has made significant contributions to research involving novel minimally invasive surgery and valvular heart disease therapies. Michael has been in practice since 1982 and has performed thousands of cardiac surgeries, of which well over 4,000 have involved heart valve procedures. Dr. Mack has spent much of his career working closely with interventional cardiologists to improve the treatment of patients with cardiovascular disease. He played critical roles in the SYNTAX Trial, which compared percutaneous coronary intervention with coronary artery bypass graft surgery in patients with three-vessel or left main disease, and the PARTNER Trial, which explored the safety and efficacy of transcatheter aortic valve replacement. He has also authored or co-authored over 400 publications in peer-reviewed journals. Dr. Mack is currently the Director of the Cardiovascular Service line at Baylor Scott & White Health System and Chairman of the Baylor Plano Research Center in Texas. Previously, he served as Medical Director Cardiovascular Disease and Transplantation at Medical City Dallas Hospital. Dr. Mack was President of the Society for Thoracic Surgeons (STS) in 2011 and a Past President of the Thoracic Surgery Foundation for Research and Education (TSFRE), the Southern Thoracic Surgical Association (STSA), and the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS). He is a member of the American College of Cardiology Foundation (ACCF) Board of Trustees and the ACC Interventional Scientific Council. He received his medical degree from St. Louis University in Missouri.

Michael Mooney works at Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, MN, USA.

Works at Houston Methodist Hospital, Houston, Texas, USA. Features in 24 videos on Wondr Medical. Michael Reardon generally speaks on Aortic Stenosis (AS), Transcatheter Aortic Valve Implantation (TAVR / TAVI), Cardiovascular Surgery, Femoral, and Mitral.

Dr. Rinaldi is board certified in cardiology and specializes in interventional cardiology and vascular medicine. He is recognized as a national and international thought leader and an expert in the fields of coronary, peripheral and structural heart interventions, including transcatheter mitral valve repair and replacement, transcatheter aortic valve replacement, transcatheter tricuspid valve repair and left atrial appendage occlusion. He is the medical director of the Structural Heart Program at Atrium Health Sanger Heart & Vascular Institute, a professor of medicine at the University of North Carolina and a faculty member of The International Andreas Gruentzig Society. He formerly served for a decade as the medical director of research of the Structural Heart Program. Dr. Rinaldi has been recognized as a Top Doctor by the Charlotte Business Journal and Physician of the Quarter by Atrium Health Carolinas Medical Center. He is a member of the Alpha Omega Alpha Honor Medical Society. As the medical director of research at Sanger Heart & Vascular Institute for 10 years, he has served as a principal or sub investigator for numerous clinical trials involving thousands of patients. His current research interests include transcatheter mitral, aortic, tricuspid valve therapies, including novel devices and techniques through clinical trials and research.

Michael Singh works at UPMC, Pittsburgh, PA, USA.

Works at SUNY Downstate College of Medicine in Brooklyn, New York, USA. Features in 1 video on Wondr Medical. Michael Weber generally speaks on General, Cardiology, Hypertension, and Renal Denervation (RDN).

Works at University Texas San Antonio, San Antonio, TX, USA. Features in 1 video on Wondr Medical. Michael Wholey generally speaks on Chronic Limb Ischaemia (CLI, coronary access) and Endovascular.

Min Ho Lee is a cardiologist at Soon Chun Hyang University Hospital, Seoul, South Korea.

Min-Woong Kim works at Hanmaeum Hospital, Hanyang University Medical Center, Seoul, Korea.

Dr Mirvat Alasnag was the first female interventional cardiologist in the Gulf region and represented women on multiple committees. She is currently the Chair of the International Working Group of the ACC Women in Cardiology Committee, a member of the SCAI Board of Trustees and ACC Interventional Leadership Council. She is also the chair of the Interventional Cardiology working group of the Tele-Cardiology Section of the International Society for Telemedicine & eHealth. She is a contributing editor & associate editor for several renowned international journals and societies including Circulation: Cardiovascular Interventions, ACCEL, Open Heart, Cardiovascular Revascularization Medicine, and PCROnline. She has served as a peer reviewer for several ACC Guideline Statements.

Works at Duke University Health System, North Carolina, USA. Features in 1 video on Wondr Medical. Mitchell Krucoff generally speaks on Drug Eluting Stents (DES) and Coronary Optical Coherence Tomography (OCT).

Works at UCSD Sulpizio Cardiovascular Center and VA San Diego, La Jolla, CA, USA. Features in 1 video on Wondr Medical. Mitul Patel generally speaks on Chronic Total Occlusion (CTO), Drug Coated Balloon (DCB), and Endovascular.

Professor of Medicine, University of Illinois; Chief, Section of Cardiology, Jesse Brown VA Medical Center

A professor of medicine at Mayo Clinic, Rochester, MN, USA. Features in 1 video on Wondr Medical. Mohamad Alkhouli generally speaks on Closure, Live Cases, Stroke: LAA and LAA closure, and Device Therapy.

Mohammad Sarraf is an interventional cardiology at University of Alabama, Birmingham, AL, USA.

Molly Szerlip is an interventional cardiologist.

Dr. Kern is Chief of Medicine, VA Long Beach Health Care System, Professor of Medicine, University California, Irvine. He continues to perform and teach cardiac catheterization and PCI. Dr. Kern is ABIM Certified in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology and is a past president and now a Master Fellow of the SCAI. His research interests in coronary blood flow, intravascular physiology, intravascular ultrasound, vulnerable plaque and evaluation of cardiovascular hemodynamics. He has authored several textbooks, notably The Cardiac Catheterization Handbook, 6th ed. and its companion The Interventional Cardiac Cath Handbook, 4th ed.

Neal Fearnot is an industry at Cook Advanced Technologies.

A consultant cardiothoracic surgeon at Royal Brompton & Harefield NHS Trust, UK. Features in 1 video on Wondr Medical. Neil Moat generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI).

An interventional cardiology at MedStar Washington Hospital Center, Washington, District of Columbia, USA. Features in 2 videos on Wondr Medical. Nelson Bernardo generally speaks on Arterial, Chronic Total Occlusion (CTO), Drug Coated Balloon (DCB), and Imaging.

An interventional cardiologist at Clinique Pasteur, Toulouse, France. Features in 1 video on Wondr Medical. Nicolas Dumonteil generally speaks on Acute Heart Failure– Treatment.

Nicolas Van Mieghem is the Clinical Director of Interventional Cardiology and Professor of Interventional Cardiology at the Thoraxcenter, Erasmus University Medical Center, Rotterdam. He obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent Fellowships in interventional cardiology in at Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, United States and Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands, he joined the senior staff of the department of interventional cardiology in the Thoraxcenter in February 2010. Professor Van Mieghem’s academic interest is in complex (calcified) coronary lesions, mechanical circulatory support and structural heart interventions. He obtained a PhD based upon his research in transcatheter valve therapies. Professor Van Mieghem is involved in the percutaneous coronary interventions and structural heart program. Professor Van Mieghem has published and co-authored over 400 scientific papers in peer-reviewed journals. He is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and the American College of Cardiology.

Nils Johnson, MD, MS, is a Professor of Medicine and holds the Weatherhead Distinguished Chair of Heart Disease at the McGovern Medical School at UTHealth (Houston). After his undergraduate degree in Vancouver, he completed medical school at Columbia University in Manhattan and trained at Northwestern University in Chicago. He is an "interventional physiologist" and his research and clinical interests span both invasive (mentored by Dr. Nico Pijls in Eindhoven) and non-invasive (mentored by Dr. Lance Gould in Houston) methods. He has served as the principal investigator for international trials like CONTRAST (NCT02184117) and DEFINE-FLOW (NCT02328820).

A cardiologist at Dresden University of Technology, Heart Center, Department of Cardiology and Intensive Care. Features in 1 video on Wondr Medical. Norman Mangner generally speaks on Cardiology and Cardiovascular Surgery.

Prof Patrick W. Serruys with respected h-index – 183 is a professor of Interventional Cardiology at the Interuniversity Cardiological Institute of the Netherlands (1988-1998) and Erasmus MC. Since 1980 he was a Director of the Clinical Research Program of the Catheterization Laboratory, Thorax Center at Erasmus University, and till April 1, 2014 (retirement date) the Head of the Interventional Department, Thorax Center, Erasmus MC (University Medical Center Rotterdam), Rotterdam, The Netherlands. Since April 2013, he holds the position of Professor of Cardiology in the Cardiovascular Science Division of the National Heart and Lung Institute (NHLI) at the Faculty of Medicine, within the Imperial College of Science, Technology and Medicine, London.He is a Fellow of the American College of Cardiology and a Fellow of the European Society of Cardiology and scientific council of the International College of Angiology.In 1996, he received the TCT Career Achievement Award and in 1997 he was awarded the Wenkebach Prize of the Dutch Heart Foundation. In 2000, he was awarded the Gruentzig Award of the European Society of Cardiology. In 2001, he held the Paul Dudley White Lecture at the American Heart Association in the USA. In 2004, he received the Andreas Gruentzig Award of the Swiss Society of Cardiology. In 2005, he held the 4th International Lecture at the AHA and Mikamo Lecture at the Japanese heart Association. In 2006, he received the highest award of the Clinical Council of the American Heart Association: the James Herrick Award. In 2007, he received the Arrigo Recordati International Prize (Italy) and the ICI Achievement Award (bestowed by the President of Israel – Shimon Perez). In 2008, he received the Einthoven Penning (Leiden). In 2009, he became Doctor Honoris Causa from the University of Athens. In 2011, he received the Lifetime Achievement Award, bestowed by the American College of Cardiology, in recognition of many years of service and invaluable contributions to the ACC. At the end of 2011, Prof Serruys received the Ray C. Fish Award, bestowed by the Texas Heart Institute, for outstanding achievement and contribution to cardiovascular medicine. In 2012, he received a Golden Medal of the European Society of Cardiology. In 2013, he became Doctor Honoris Causa from the Complutense University of Madrid. In 2016, he became Doctor Honoris Causa of the Melbourne University, Australia. Currently he is established Professor of Interventional Medicine and Innovation at the National University of Ireland, Galway.

Works at Johns Hopkins University School of Medicine, Washington, DC, USA. Features in 2 videos on Wondr Medical. Paul Gurbel generally speaks on Anti-Platelet Drugs , Drug Eluting Stents (DES), Acute Coronary Syndromes (ACS), and Anticoagulants.

Paul Sorajja works at Abbott Northwestern Hospital, Minneapolis, MN, USA.

Perwaiz Meraj works at Northwell Health, Manhasset, NY, USA.

Works at Morristown Medical Center, Morristown, NJ, USA. Features in 5 videos on Wondr Medical. Philippe Genereux generally speaks on Shockwave Lithotripsy (Coronary), Coronary Optical Coherence Tomography (OCT), Stable Coronary Artery Disease (CAD), and Calcified Lesions.

Pieter Smits works at Maasstad Ziekenhuis, Rotterdam, Netherlands.

Works at John F. Kennedy Medical Center/Newark Beth Israel Medical Center, Warren, NJ, USA. Features in 1 video on Wondr Medical. Raj Tayal generally speaks on Impella, Shockwave Lithotripsy (Coronary), Calcified Iliac Disease, and Alternative Access.

Works at MedStar Heart and Vascular Institute, Washington, DC, USA. Features in 2 videos on Wondr Medical. Rajesh Malik generally speaks on Abdominal Aortic Aneurysm (AAA).

Rajesh Swaminathan is an associate professor of medicine at Duke University Medical Center, Durham, NC, USA.

Raymond Givens is an assistant professor of medicine at Columbia University Medical Center, New York, USA.

Reginald Low is an interventional cardiology at UC Davis Medical Center,Sacramento, CA, USA.

A consultant cardiologist at Dante Pazzanese Institute, Sao Paulo, Brazil. Features in 2 videos on Wondr Medical. Ricardo Costa generally speaks on Medical Device.

Richard Benson works at MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Richard Jabbour is an interventional cardiology fellow at Hammersmith Hospital, Imperial College London, UK.

A consultant vascular surgeon at INOVA Fairfax Hospital, Falls Church, VA, USA. Features in 2 videos on Wondr Medical. Richard Neville generally speaks on Drug Eluting Stents (DES), Drug Coated Balloon (DCB), Chronic Limb Ischaemia (CLI, coronary access), and Peripheral Vascular Disease (PVD).

Works at Swedish Heart and Vascular, Seattle, WA, USA. Features in 1 video on Wondr Medical. Robert Bersin generally speaks on Aorta and Endovascular.

Robert Gallino is an interventional cardiology at Cardiology Associates, LLC, Olney, Maryland, USA.

Robert Lederman works at National Institutes of Health/National Heart, Lung, and Blood Institute, Bethesda, MD, USA.

Robert Wilensky works at University of Pennsylvania Health System, Philadelphia, PA, USA.

Robert W. Yeh, MD MSc is Associate Chief of Interventional Cardiology at the Beth Israel Deaconess Medical Center and the Katz-Silver Associate Professor of Medicine at Harvard Medical School. He is an expert in complex coronary intervention, including chronic total occlusion PCI. He is also the founding Director the Smith Center for Outcomes Research at BIDMC.

Works at Thorax Centre Erasmus MS, Rotterdam, The Netherlands. Features in 15 videos on Wondr Medical. Robert-Jan Van Geuns generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI), Live Cases, Left Main Stem (LMS), Rotational Atherectomy, and Intravascular Ultrasound (IVUS).

Rocco A. Armonda, MD, is director of Neuroendovascular Surgery for MedStar Washington Hospital Center and MedStar Georgetown University Hospital, surgical co-director for the Neuro Intensive Care Unit at MedStar Washington, and associate professor and director of Neurosurgery at the Uniformed Services University of the Health Sciences (USUHS).

Dr Colleran is a Consultant interventional cardiologist at Mater Private Hospital Dublin and Cardiovascular Research Institute Dublin. Her specialty interests include general and interventional cardiology. Her areas of expertise include cardiac catheterisation, angioplasty and stenting, quantitative coronary angiography, optical coherence tomography, and coronary physiology. Her specific areas of interest are high-risk patient and lesions subsets undergoing percutaneous coronary intervention, patients at high bleeding risk, antithrombotic therapies in patients undergoing coronary stenting, drug-eluting stent and balloon technologies, myocardial revascularisation failure and structural intervention.

Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.

Works at St. Joseph's Hospital, Syracuse NY, USA. Features in 1 video on Wondr Medical. Ronald Caputo generally speaks on Femoral and Radial.

Roseann White works at Duke Clinical Research Institute, Chapel Hill, NC, USA.

A consultant cardiologist at Mount Sinai Hospital, New York, USA. Features in 13 videos on Wondr Medical. Roxana Mehran generally speaks on Anti-Platelet Drugs , Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), Cardiovascular Pharmacotherapy, and Cardiac Valves.

Ryan Madder is an industry at Spectrum Health, Ada, MI, USA.

Salvatore F Mannino is an interventional cardiologist at Wellstar Cardiovascular Medicine, Marietta, GA, USA.

A consultant cardiologist at CardioVascular Center, Frankfurt, Germany. Features in 7 videos on Wondr Medical. Sameer Gafoor generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI), Mitral, Aortic Pathology, Aortic Valve Pathology, and Aortic dissection.

Works at The Commonwealth Medical College, Scranton, Clarks Summit, PA, USA. Features in 1 video on Wondr Medical. Samir Pancholy generally speaks on Radial and Acute Coronary Syndromes (ACS).

A clinical associate professor at Chungbuk National University Hospital, Korea. Features in 1 video on Wondr Medical. Sang Yeub Lee generally speaks on Intravascular Ultrasound (IVUS), Bifurcation, and Stable Coronary Artery Disease (CAD).

Sang-Ho Park works at Soonchunhyang University Cheonon Hospital, Cheonan, Korea.

Santanu Biswas is an interventional cardiologist at Intermountain Heart Institute, Murray, UT, USA.

Selma Mohammed works at MedStar Washington Hospital Center, Washington, District of Columbia, USA.

Works at Korea University Guro Hospital, Seoul, Republic of Korea. Features in 1 video on Wondr Medical. Seung-Woon Rha generally speaks on Cardiology.

A medical doctor at Emory Healthcare, United States of America. Features in 5 videos on Wondr Medical. spencer King generally speaks on Cardiology, Structural Cardiac Interventions, and Interventional Cardiology - Other.

Dr. Bangalore is an interventional cardiologist and a Professor of Medicine at New York University School of Medicine. He is the Director of Complex Coronary Intervention; Director of Research for the cardiac catheterization laboratory and the Director for the Cardiovascular Outcomes Group. His clinical expertise is in complex coronary intervention including CTOs, ultra low volume/zero contrast PCI, and renal denervation. His research interests are in comparative effectiveness studies for cardiovascular diseases, particularly stable ischemic heart disease, acute coronary syndromes, hypertension and dyslipidemia. Dr. Bangalore has received grants from the National Institutes of Health, Agency for Healthcare Research and Quality, American Heart Association and from the industry. He has published over 350 articles in leading national and international journals including the NEJM, JAMA, Lancet, Circulation and JACC. He is the principal investigator of the ISCHEMIA CKD trial, which is a randomized trial in patients with advanced chronic kidney disease and abnormal stress test, carried out in 33 countries and up to 350 clinical sites. The trial is testing the effectiveness of an initial invasive strategy of cath and revascularization with optimal medical therapy versus a conservative strategy of optimal medical therapy alone in patients with chronic kidney disease. His other areas of interest include comparative effectiveness of coronary artery bypass surgery (CABG) vs. percutaneous coronary intervention (PCI), evaluating the efficacy and safety of various stent types in patients undergoing PCI, including patients with diabetes and those in patients with ST segment elevation myocardial infarction and comparative effectiveness of drug eluting stents vs. bare metal stents. He has won a number of awards including the Dr. Gregory Braden Memorial Interventional Cardiology Fellow of the Year Award from the Society for Cardiovascular Angiography and Intervention and the Douglas P. Zipes Distinguished Young Scientist award from the American College of Cardiology.

A consultant cardiologist at Department of Veterans Affairs, Minnesota, US. Features in 1 video on Wondr Medical. Stephan Bertog generally speaks on Covid-19 and Covid19 Physician Insights.

Works at Cardiovascular Center Bern, Bern Universität Hospital, Bern, Switzerland. Features in 1 video on Wondr Medical. Stephan Windecker generally speaks on Cardiac Valves.

Stephen Bailey is a cardiothoracic surgeon at Allegheny health network, Pennsylvania, US.

Stephen Ellis works at Cleveland Clinic, Ohio, USA.

Stephen W. Waldo is a cardiologist at Veterans Affairs Eastern Colorado Healthcare System, University of Colorado, Denver, CO, USA.

Dr. Steven Bailey is The Chairman of Medicine at LSU Shreveport and the Malcolm Feist Chair of Interventional Cardiology. He also is a Tenured and Emeritus Professor of Medicine and Radiology and previous Chief of the Janey and Dolph Briscoe Jr. Division of Cardiology at the University of Texas Health Science Center in San Antonio, Texas. Dr. Bailey received his medical degree from University of Oregon Health Science Center at Portland and did his medicine residency and cardiology fellowship at Fitzsimmons Army Medical Center in Aurora, Colorado. He is board certified by the American Board of Internal Medicine with subspecialty board certification in both Cardiovascular Disease and Interventional Cardiology. Dr. Bailey's clinical focus is in Adult Congenital/Structural and Valvular heart disease in addition to Coronary Atherosclerotic Disease. His research laboratory is involved in investigating the effects of NOX subtypes in promoting cardiovascular disease. He has translational research in the field of nanotechnologies and nanosensors and holds several patents in these fields. He was the Program Director for Interventional Cardiology at UTHSCSA from 1999 to 2019. Dr. Bailey chaired the UTHSCSA Promotion and Tenure committee. Dr. Bailey is a Past President of the Society for Cardiovascular Angiography and Interventions (SCAI) and is currently the Editor in Chief of Catheterization and Cardiovascular Interventions, which is the official publication of SCAI. He is a Master Fellow of SCAI, Fellow of the American College of Cardiology and a Fellow the American College of Physicians. He is a member of the Association of University Cardiologists, Association of Cardiology Professors as well as the International Andreas Greuntizig Society.

Steven Goldberg works at Kalispell Regional Medical Center, Whitefish, MT, USA.

Steven Goldstein works at MedStar Washington Hospital Center, Washington, District of Columbia, USA and features in 1 video on Wondr Medical.

Steven Nissen works at Cleveland Clinic, Cleveland, OH, USA.

Works at OhioHealth/Riverside Methodist Hospital, Columbus, OH, USA. Features in 1 video on Wondr Medical. Steven Yakubov generally speaks on Transcatheter Aortic Valve Implantation (TAVR / TAVI) and Aortic Stenosis (AS).

Dr. Rao is Professor of Medicine at Duke University Medical Center, and the Section Chief of Cardiology at the Durham VA Medical Center. At the national level, Dr. Rao serves as the Editor-in-Chief for Circulation Cardiovascular Interventions, the interventional journal of the American Heart Association’s flagship Circulation family of journals. He is the President-Elect for The Society for Cardiovascular Angiography and Interventions, and serves on the program committees of the ACC Scientific Sessions, the Transcatheter Cardiovascular Therapeutics conference, and the SCAI Scientific Sessions. He was the chairman of the 2017 ACC-i2 Summit and was the chair of the SCAI 2019 Annual Scientific Session. In addition, he was the Editor-in-Chief of the ACC CathSAP 5 program and is currently the co-chair of the ACC Collaborative Management Pathway for Interventional Cardiology. His main research interests are pharmacological and interventional therapies for acute coronary syndromes, as well as bleeding and blood transfusion complications among patients with ischemic heart disease. Dr. Rao has published over 300 peer-reviewed papers, and is the co-Editor-in-Chief of the seminal textbook on transradial procedures titled “Best Practices for Transradial Approach in Diagnostic Angiography and Intervention.”

A medical doctor at Wakayama Medical University, Wakayama, Japan. Features in 16 videos on Wondr Medical. Takashi Akasaka generally speaks on Instantaneous wave-Free Ratio (iFR), Fractional Flow Reserve (FFR), Coronary Flow Reserve (CFR), Coronary Physiology, and Coronary Optical Coherence Tomography (OCT).

Tamara Atkinson is a cardiologist at Oregon Health and Science University, Portland, Oregon, USA.

Thomas Pilgrim works at University of Bern, Bern, Switzerland.

Works at Universitäts-Herzzentrum Freiburg, Bad Krozingen, Baden-Wurttemberg, Germany. Features in 19 videos on Wondr Medical. Thomas Zeller generally speaks on Drug Eluting Stents (DES), Drug Coated Balloon (DCB), Chronic Limb Ischaemia (CLI, coronary access), Critical Limb Ischaemia (peripheral), and Peripheral Vascular Disease (PVD).

Tim Fischell works at Borgess Heart Institute, Kalamazoo, MI, USA.

Tobias Schmidt is a cardiologist at University of Cologne, Cologne, Germany.

Dr. Rogers is an interventional cardiologist and scientific lead for the MedStar Heart & Vascular Institute Structural Heart Disease program. He has a special interest in all aspects of minimally invasive treatment of structural heart disease, including Transcatheter Aortic Valve Replacement (TAVR), Transcaval access, Transcatheter Electrosurgery (LAMPOON and BASILICA techniques), para-valvular leak closure, percutaneous treatment of mitral valve regurgitation including Mitraclip and Transcatheter Mitral Valve Replacement (TMVR), LAA occluder, percutaneous pulmonary and tricuspid valve interventions, and cerebral protection devices for TAVR.

A professor of medicine at Stanford University School of Medicine, California, USA. Features in 3 videos on Wondr Medical. Todd J Brinton generally speaks on Aortic Valve Pathology, Shockwave Lithotripsy (Coronary), Stable Coronary Artery Disease (CAD), and Device Therapy.

Tom C. Nguyen is Chief of Cardiac Surgery, Associate Professor of Cardiothoracic Surgery and Director of Minimally Invasive Valve Surgery at the University of Texas-Memorial Hermann in Houston, Texas. His clinical and academic interest is structural heart disease, including TAVR, MitraClip, minimally invasive valve surgery, mitral valve repairs, and complex adult cardiac surgery.

Vandana Mukhi is an assistant director at U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Vasilios Papademetriou works at Georgetown University/VAMC,Washington, DC, USA.

Victor Jimenez Diaz is a consultant cardiologist at Hospital Alvaro Cunqueiro,. University Hospital of Vigo, Spain.

Vinod Thourani is a professor of surgery at MedStar Heart and Vascular Institute, Washington, DC, USA.

Works at Wake Forest Univ - Baptist Hospitals, Winston Salem, NC, USA. Features in 1 video on Wondr Medical. Walter Tan generally speaks on Chronic Limb Ischaemia (CLI, coronary access) and Endovascular.

Wayne Batchelor works at Southern Medical Group, Tallahassee, Fl, USA.

William Cooper is an assistant professor of pediatrics at Vanderbilt University, Nashville, TN.

Works at Lankenau Heart Institute, Main Line Health, Wynnewood, PA. Features in 8 videos on Wondr Medical. William Gray generally speaks on Stroke, Peripheral Vascular Disease (PVD), Stroke: LAA and LAA closure, Left Atrial Appendage (Closure), and Venous (PVD).

Dr. William Nicholson is acting Associate Professor of Medicine at Emory University School of Medicine and Director of Complex Coronary and Cardiac Intervention at Emory Healthcare. Dr. Nicholson also serves as the program director for the Advanced Complex High-Risk Interventional Procedures (CHIP) fellowship at Emory University Hospital. Dr. Nicholson came to Emory in 2020 after fourteen years in private interventional cardiology practice in York, Pennsylvania. While in private practice, Dr. Nicholson founded and developed that institution’s carotid stenting program, structural heart program, transcatheter aortic valve replacement program, and the complex coronary intervention program. He also has become nationally and internationally recognized for his expertise in treatment of Chronic Total Occlusions (CTO’s). He is a perennial live case operator for nationally televised conferences. Dr. Nicholson formerly trained at Emory University Hospital having completed his general cardiology and interventional fellowship in 2006. He completed his medical residency at Brown University Hospitals where he also served as Chief Medical Resident. He is a graduate of Pennsylvania State College of Medicine.

William Weintraub works at Christiana Care Health System, Newark, DE, USA.

Wolfran Bougouin is an interventional cardiologist at Sudden death expertise centre, Paris, France.

Won Ho Kim is a cardiologist at Eulji University, Daejeon, South Korea.

Won-Young Jang is a cardiologist at Korea University Guro Hospital, Seoul, Korea.

Woong Gil Choi is an interventional cardiology at Konkuk University Chungju Hospital, Seoul, Korea.

Yoke Loong Foo works at University Putra Malaysia, Kuala Lumpur, Malaysia.

Works at Cardialysis, Rotterdam, The Netherlands. Features in 3 videos on Wondr Medical. Yoshinobu Onuma generally speaks on Imaging, Intravascular Ultrasound (IVUS), Coronary Optical Coherence Tomography (OCT), Fractional Flow Reserve (FFR), and Instantaneous wave-Free Ratio (iFR).

Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.

Dr. Ziyad Ghazzal earned his MD at AUB Faculty of Medicine and completed his residency in internal medicine at AUBMC in 1984. Dr. Ghazzal has upheld an academic rigor in all his professional life, becoming an internationally renowned interventional cardiologist who has excelled as a highly accomplished clinician, researcher, and teacher/ mentor. He was promoted to Professor of Medicine at Emory University, Atlanta, GA, where he has been a full-time faculty member since 1990, after completing his fellowship training at the same institution from 1985 to 1990. Dr. Ghazzal has published extensively in the cardiology literature, including high-quality original papers and many other reviews, editorials, book chapters, and video seminars. He is regularly sought after by international organizations for clinical lectures, tutorials, and other CME activities in the area of interventional cardiology. As a director of the Interventional Fellowship Program at Emory, Dr. Ghazzal has played an instrumental role in the success of the training program there, one of the premier programs in the United States. He has been a member of a large number of prospective multicenter clinical trials, including being the local principal investigator at Emory. He was an associate editor of the popular 'Cardiosource', the official teaching website of the American College of Cardiology. He was also the co-chair of the international distant learning program of the College. He is an editorial consultant for JACC Cardiovascular Interventions and the American Journal of Cardiology. Dr. Ghazzal is an Alpha Omega Alpha member and has received many honors, including the Medical Leadership Award from the National Association of North America, and the Excellence in Teaching Award from Emory University. In 2008 Dr. Ghazzal joined the American University of Beirut where he functioned as the Deputy to the Executive Vice President/Dean of the Faculty of Medicine and Medical Center in addition to his duties as an interventional cardiologist. He was appointed interim Medical Center Director and Chief Medical Officer (2017-2020). He is the Founding Director of the Heart & Vascular Institute and currently serves as the Director of the Moufid Farra Heart, Vascular & Kidney outpatient center.

Zorina Galis works at National Institutes of Health, Bethesda, MD, USA.